At the beginning of the year, the Department of Veterans Affairs issued a Request for Applications (RFA) to study the use of FDA-designated Breakthrough Therapies, including MDMA-Assisted Therapy and psilocybin, to treat veterans who suffer from PTSD and depression. This announcement marks the VA's first-ever direct investment in support of these studies, and signals a significant policy shift in favor of MDMA and psychedelic-assisted therapies within the VA health care system. The VA's announcement marks a huge victory for the leading federal veteran advocacy group for MDMA-Assisted Therapy, Healing Breakthrough.

Read the press release here.